Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Berger

Showing results (281-290 of 665) with videos related to

Pageof 67
Sort By:
HNO|July 7, 2012
[Clinical use of a micromanipulator system: preliminary clinical experience in middle ear surgery]G Strauss, T Maier, M Krinninger, et al.
Frontiers in Immunology|November 30, 2023
Case Report: Gene expression profiling of COVID-19 vaccination-related lymphadenopathies reveals evidence of a dominantly extrafollicular immune responseThomas Menter, Carl P Zinner, Christoph T Berger, et al.
The British Journal of Ophthalmology|November 1, 1988
BlepharochalasisD J Bergin, C D McCord, T Berger, et al.
Annals of the Rheumatic Diseases|January 24, 2019
Serial IL-6 measurements in patients with tocilizumab-treated large-vessel vasculitis detect infections and may predict early relapsesChristoph T Berger, Birke Rebholz-Chaves, Mike Recher, et al.
Journal of Palliative Medicine|April 30, 2005
Communication in caring for terminally ill patientsJ T Berger, F Rosner, J Potash, et al.
Theriogenology|February 2, 1994
Evaluation of relative fertility of cryopreserved goat spermT Berger, E Z Drobnis, L Foley, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 9, 2023
A diagnostic performance study of the 2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis in a cohort of patients presenting with suspected giant cell arteritisAndrea K Hemmig, Markus Aschwanden, Stephan Imfeld, et al.
Neurology|April 24, 1999
Bioavailability of interferon beta 1b in MS patients with and without neutralizing antibodiesF Deisenhammer, M Reindl, J Harvey, et al.
Archives of Internal Medicine|July 25, 2000
Disclosure and prevention of medical errors. Committee on Bioethical Issues of the Medical Society of the State of New YorkF Rosner, J T Berger, P Kark, et al.
Clinical and Experimental Immunology|February 5, 1999
Expression of CD30 mRNA, CD30L mRNA and a variant form of CD30 mRNA in restimulated peripheral blood mononuclear cells (PBMC) of patients with helminthic infections resembling a Th2 diseaseJ Kilwinski, T Berger, J Mpalaskas, et al.
Pageof 67

Showing results (281-290 of 665) with videos related to

Sort By:
Pageof 67
HNO|July 7, 2012
[Clinical use of a micromanipulator system: preliminary clinical experience in middle ear surgery]G Strauss, T Maier, M Krinninger, et al.
Frontiers in Immunology|November 30, 2023
Case Report: Gene expression profiling of COVID-19 vaccination-related lymphadenopathies reveals evidence of a dominantly extrafollicular immune responseThomas Menter, Carl P Zinner, Christoph T Berger, et al.
The British Journal of Ophthalmology|November 1, 1988
BlepharochalasisD J Bergin, C D McCord, T Berger, et al.
Annals of the Rheumatic Diseases|January 24, 2019
Serial IL-6 measurements in patients with tocilizumab-treated large-vessel vasculitis detect infections and may predict early relapsesChristoph T Berger, Birke Rebholz-Chaves, Mike Recher, et al.
Journal of Palliative Medicine|April 30, 2005
Communication in caring for terminally ill patientsJ T Berger, F Rosner, J Potash, et al.
Theriogenology|February 2, 1994
Evaluation of relative fertility of cryopreserved goat spermT Berger, E Z Drobnis, L Foley, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 9, 2023
A diagnostic performance study of the 2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis in a cohort of patients presenting with suspected giant cell arteritisAndrea K Hemmig, Markus Aschwanden, Stephan Imfeld, et al.
Neurology|April 24, 1999
Bioavailability of interferon beta 1b in MS patients with and without neutralizing antibodiesF Deisenhammer, M Reindl, J Harvey, et al.
Archives of Internal Medicine|July 25, 2000
Disclosure and prevention of medical errors. Committee on Bioethical Issues of the Medical Society of the State of New YorkF Rosner, J T Berger, P Kark, et al.
Clinical and Experimental Immunology|February 5, 1999
Expression of CD30 mRNA, CD30L mRNA and a variant form of CD30 mRNA in restimulated peripheral blood mononuclear cells (PBMC) of patients with helminthic infections resembling a Th2 diseaseJ Kilwinski, T Berger, J Mpalaskas, et al.
Pageof 67